SK Bioscience introduces AI into flu vaccine production to help improve yields
Predicted impact: Low
AI adoption in vaccine production already reported; incremental yield benefit is vague and unquantified.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.